Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giampaolo Tortora

Showing results (1-10 of 492) with videos related to

Pageof 50
Sort By:
Journal of the National Cancer Institute. Monographs|November 2, 2011
Mechanisms of resistance to HER2 target therapyGiampaolo Tortora
Cancer Discovery|August 4, 2016
Adipocytes and Neutrophils Give a Helping Hand to Pancreatic CancersVincenzo Bronte, Giampaolo Tortora
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Protein kinase A type I: a target for cancer therapyGiampaolo Tortora, Fortunato Ciardiello
Tumori|February 25, 2003
[Rationales for the integration of molecular and conventional therapies]Giampaolo Tortora, Fortunato Ciardiello
Expert Opinion on Investigational Drugs|May 31, 2002
Anti-epidermal growth factor receptor drugs in cancer therapyFortunato Ciardiello, Giampaolo Tortora
Seminars in Oncology|August 15, 2003
Antisense strategies targeting protein kinase C: preclinical and clinical developmentGiampaolo Tortora, Fortunato Ciardiello
The New England Journal of Medicine|March 14, 2008
EGFR antagonists in cancer treatmentFortunato Ciardiello, Giampaolo Tortora
Mayo Clinic Proceedings. Digital Health|May 22, 2026
From P4 Medicine Hype to Digital Health MaturityAlfredo Cesario, Giampaolo Tortora
The New England Journal of Medicine|November 5, 2025
Vepdegestrant in Advanced Breast CancerGiovanni Trovato, Giampaolo Tortora
Annals of the New York Academy of Sciences|January 31, 2004
Antisense targeting protein kinase A type I as a drug for integrated strategies of cancer therapyGiampaolo Tortora, Fortunato Ciardiello
Pageof 50

Showing results (1-10 of 492) with videos related to

Sort By:
Pageof 50
Journal of the National Cancer Institute. Monographs|November 2, 2011
Mechanisms of resistance to HER2 target therapyGiampaolo Tortora
Cancer Discovery|August 4, 2016
Adipocytes and Neutrophils Give a Helping Hand to Pancreatic CancersVincenzo Bronte, Giampaolo Tortora
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 13, 2002
Protein kinase A type I: a target for cancer therapyGiampaolo Tortora, Fortunato Ciardiello
Tumori|February 25, 2003
[Rationales for the integration of molecular and conventional therapies]Giampaolo Tortora, Fortunato Ciardiello
Expert Opinion on Investigational Drugs|May 31, 2002
Anti-epidermal growth factor receptor drugs in cancer therapyFortunato Ciardiello, Giampaolo Tortora
Seminars in Oncology|August 15, 2003
Antisense strategies targeting protein kinase C: preclinical and clinical developmentGiampaolo Tortora, Fortunato Ciardiello
The New England Journal of Medicine|March 14, 2008
EGFR antagonists in cancer treatmentFortunato Ciardiello, Giampaolo Tortora
Mayo Clinic Proceedings. Digital Health|May 22, 2026
From P4 Medicine Hype to Digital Health MaturityAlfredo Cesario, Giampaolo Tortora
The New England Journal of Medicine|November 5, 2025
Vepdegestrant in Advanced Breast CancerGiovanni Trovato, Giampaolo Tortora
Annals of the New York Academy of Sciences|January 31, 2004
Antisense targeting protein kinase A type I as a drug for integrated strategies of cancer therapyGiampaolo Tortora, Fortunato Ciardiello
Pageof 50